Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis
Josson, S, Gururajan, M, Sung, S Y, Hu, P, Shao, C, Zhau, H E, Liu, C, Lichterman, J, Duan, P, Li, Q, Rogatko, A, Posadas, E M, Haga, C L, Chung, L W K
Published in Oncogene (21.05.2015)
Published in Oncogene (21.05.2015)
Get full text
Journal Article
Proteomic analysis for the early detection and rational treatment of cancer—realistic hope?
Posadas, E. M., Simpkins, F., Liotta, L. A., MacDonald, C., Kohn, E. C.
Published in Annals of oncology (01.01.2005)
Published in Annals of oncology (01.01.2005)
Get full text
Journal Article
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
Alyamani, M., Li, J., Patel, M., Taylor, S., Nakamura, F., Berk, M., Przybycin, C., Posadas, E.M., Madan, R.A., Gulley, J.L., Rini, B., Garcia, J.A., Klein, E.A., Sharifi, N.
Published in Annals of oncology (01.03.2020)
Published in Annals of oncology (01.03.2020)
Get full text
Journal Article
Interim results of a phase Ib study of niraparib plus androgen receptor-targeted therapy in men with metastatic castration-resistant prostate cancer
Saad, F., Chi, K.N., Shore, N., Graff, J.N., Posadas, E.M., Freeman, S., Tryon, J., Trudel, G.C., de Jong, J., Meltzer, J., Zhao, X., Tran, N., Rezazadeh, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium Department of Defense Prostate Cancer Clinical Trials Consortium study
Ward, J E, Karrison, T, Chatta, G, Hussain, M, Shevrin, D, Szmulewitz, R Z, O'Donnell, P H, Stadler, W M, Posadas, E M
Published in Prostate cancer and prostatic diseases (01.03.2012)
Published in Prostate cancer and prostatic diseases (01.03.2012)
Get full text
Journal Article
Deep AR suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
Alyamani, M., Li, J., Patel, M., Taylor, S., Nakamura, F., Berk, M., Przybycin, C., Posadas, E. M., Madan, R.A., Gulley, J. L., Rini, B., Garcia, J., Klein, E., Sharifi, N.
Published in Annals of oncology (11.02.2020)
Published in Annals of oncology (11.02.2020)
Get full text
Journal Article
834PInterim results of a phase Ib study of niraparib plus androgen receptor-targeted therapy in men with metastatic castration-resistant prostate cancer
Saad, F, Chi, K N, Shore, N, Graff, J N, Posadas, E M, Freeman, S, Tryon, J, Trudel, G C, de Jong, J, Meltzer, J, Zhao, X, Tran, N, Rezazadeh, A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Fluorescence-activated cell sorting (FACS) and immunofluorescence (IF) detection and characterization of circulating tumor cells (CTC) from men with castrate-resistant prostate cancer (CRPC)
Szmulewitz, R. Z., Wyche, A. J., Posadas, E. M., Stadler, W. M.
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled phase II study of testosterone replacement in men with asymptomatic castrate-resistant prostate cancer (PC)
Szmulewitz, R. Z., Posadas, E. M., Manchen, B., Stadler, W. M.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Frontiers in prostate cancer. Telomeres and chaos
Sommerfeld, Hans J., Meeker, Alan K., Posadas, Edwin M., Coffey, Donald S.
Published in Cancer (01.04.1995)
Published in Cancer (01.04.1995)
Get full text
Journal Article
Conference Proceeding
A randomized phase II study of pazopanib in castrate-sensitive prostate cancer: A University of Chicago phase II consortium/DoD Prostate Cancer Clinical Trials Consortium study
Ward, J. E., Limvorasak, S., Karrison, T., Chatta, G. S., Hussain, M., Shevrin, D. H., Szmulewitz, R. Z., Stadler, W. M., Posadas, E. M.
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Phase II study of AT-101 to abrogate Bcl-2-mediated resistance to androgen-deprivation therapy (ADT) in patients (pts) with newly diagnosed androgen-dependent metastatic prostate cancer (ADMPC)
Stein, M. N., Khan, I., Hussain, M., Liu, G., Wilding, G., Posadas, E. M., Stadler, W. M., Jeyamohan, C., Eddy, S., DiPaola, R. S.
Published in Journal of clinical oncology (01.03.2011)
Published in Journal of clinical oncology (01.03.2011)
Get full text
Journal Article
Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy
Posadas, E. M., Tannir, N. M., Wong, Y., Ernstoff, M. S., Kollmannsberger, C. K., Qian, J., Ansell, P. J., McKeegan, E. M., McKee, M. D., Ricker, J. L., Carlson, D. M., Michaelson, M. D.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase II trial of linifanib in patients with advanced renal cell cancer (RCC) after sunitinib failure
Tannir, N. M., Wong, Y., Kollmannsberger, C. K., Ernstoff, M. S., Perry, D. J., Appleman, L. J., Posadas, E. M., Qian, J., Ricker, J. L., Michaelson, D.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A phase II trial of gemcitabine(G), capecitabine (C), and bevacizumab (B) in patients (pts) with metastatic renal cell carcinoma (RCC)
Chung, E. K., Posadas, E. M., Kasza, K., Karrison, T., Manchen, E., Michalak, L., Hahn, O. M., Stadler, W. M.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article